[ European Foundation For the Study of Diabetes (EFSD) and Sanofi I Research funding for measurement of diabetes outcomes ]
Event details
| Date | 02.03.2020 |
| Category | Call for proposal |
EFSD and Sanofi have established a new programme called the EFSD/Sanofi European Pilot Research Grants for Innovative Measurement of Diabetes Outcomes to encourage new projects aimed at advancing current knowledge in this field.
HbA1c might not be the only “metric” of relevance to assess the possibility for a treatment strategy to provide long term benefit and improved quality of life to patients with diabetes. The life-long duration of the disease, the economic, social, psychological, and physiological burden and limited appreciation of individual needs are likely important interfering factors.
These EFSD/Sanofi European Pilot Research Grants are intended to help develop innovative means to document and validate novel parameters indicative of long-term benefits for patients with diabetes.
Proposals may include, but need not be limited to, the validation of behavioural, biological, and disease management metrics to complement HbA1c in defining the quality of the long term management of diabetes.
Who can apply:
Funding & Duration:
Deadline: 2 March 2020 at 18:00 (CET)
Decision: July 2020.
For further information, please have a look at the call webpage (incl. evaluation criteria), general instructions, online application portal (incl. the online application form) and past grantees.
HbA1c might not be the only “metric” of relevance to assess the possibility for a treatment strategy to provide long term benefit and improved quality of life to patients with diabetes. The life-long duration of the disease, the economic, social, psychological, and physiological burden and limited appreciation of individual needs are likely important interfering factors.
These EFSD/Sanofi European Pilot Research Grants are intended to help develop innovative means to document and validate novel parameters indicative of long-term benefits for patients with diabetes.
Proposals may include, but need not be limited to, the validation of behavioural, biological, and disease management metrics to complement HbA1c in defining the quality of the long term management of diabetes.
Who can apply:
- The principal investigator and any co-investigators must be employed full-time at a non-profit institution in the EU or Associated Countries and the study must be performed at their place of work.
- Applicants to all EFSD programmes must be paid-up members of EASD.
- Only one EFSD award per PI or Co-PI at a time.
- There can be more than one EFSD award per lab, but for separate projects.
Funding & Duration:
- Max. EUR 100’000 for 12 months or longer.
- The budget must be prepared in EUR and it must mention the exchange rate.
- Please mention all funding requested and obtained from other sources.
- Eligible costs: personnel, 10% OH, equipment, supplies, other project-related costs.
Deadline: 2 March 2020 at 18:00 (CET)
Decision: July 2020.
For further information, please have a look at the call webpage (incl. evaluation criteria), general instructions, online application portal (incl. the online application form) and past grantees.
Practical information
- General public
- Free